UBS AM’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $967K | Buy |
284,350
+92,726
| +48% | +$315K | ﹤0.01% | 2393 |
|
|
2025
Q1 | $768K | Sell |
191,624
-5,434
| -3% | -$21.8K | ﹤0.01% | 2404 |
|
|
2024
Q4 | $1.28M | Buy |
197,058
+22,433
| +13% | +$146K | ﹤0.01% | 2261 |
|
|
2024
Q3 | $967K | Sell |
174,625
-24,528
| -12% | -$136K | ﹤0.01% | 2413 |
|
|
2024
Q2 | $1.11M | Buy |
199,153
+75,022
| +60% | +$419K | ﹤0.01% | 2323 |
|
|
2024
Q1 | $833K | Buy |
124,131
+1,015
| +0.8% | +$6.81K | ﹤0.01% | 2099 |
|
|
2023
Q4 | $1.12M | Buy |
123,116
+11,593
| +10% | +$106K | ﹤0.01% | 1964 |
|
|
2023
Q3 | $616K | Buy |
111,523
+47,428
| +74% | +$262K | ﹤0.01% | 2204 |
|
|
2023
Q2 | $589K | Hold |
64,095
| – | – | ﹤0.01% | 2254 |
|
|
2023
Q1 | $589K | Buy |
64,095
+1,063
| +2% | +$9.77K | ﹤0.01% | 2254 |
|
|
2022
Q4 | $644K | Sell |
63,032
-6,790
| -10% | -$69.3K | ﹤0.01% | 2068 |
|
|
2022
Q3 | $1.03M | Buy |
69,822
+5,865
| +9% | +$86.3K | ﹤0.01% | 1954 |
|
|
2022
Q2 | $686K | Buy |
+63,957
| New | +$686K | ﹤0.01% | 2156 |
|